Back to search results

Hydrogen's Feasibility and Safety as a Therapy in ECPR

Abroad (travel likely)RecruitingPHASE1

Conditions

Cardiac Arrest · Extracorporeal Membrane Oxygenation · Reperfusion Injury

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Children's National Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Bao (Robyn) Nguyen Puente, MD) · bpuente@childrensnational.org

  • Boston Children's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (John Kheir, MD) · john.kheir@childrens.harvard.edu · 8576368890
    Contact: Principal Investigator (John Kheir, MD)
    Victoria Habet, DO (Sub-investigator)

  • Children's Mercy Kansas City, Kansas City, Missouri, United States

    Contact: Study coordinator (Niranjan Vijayakumar, MBBS) · nvijayakumar1@cmh.edu

  • Primary Children's Hospital, Salt Lake City, Utah, United States

    Contact: Study coordinator (Stephanie Goldstein, MD) · stephanie.goldstein@hsc.utah.edu
Study leads

  • John N Kheir, MD

    Principal Investigator

    Associate Professor of Pediatrics, Harvard Medical School

View source on ClinicalTrials.gov(opens in a new tab)